FIELD: medicine, ophthalmology.
SUBSTANCE: invention is intended for the treatment or prevention of a condition, disorder or disease of the corneal endothelium. Compound (T)EW-7197(N-((4-([1,2,4]triazolo[1,5-a]pyridin-6-yl)-5-(6-methylpyridin-2-yl)-1H-imidazol-2-yl)methyl)-2-fluoroaniline) or a derivative thereof, or a pharmaceutically acceptable salt thereof, or a solvate thereof is used either for treatment or prevention of a condition, disorder or disease of the corneal endothelium.
EFFECT: effective treatment or prevention of a condition, disorder or disease of the corneal endothelium.
10 cl, 9 dwg, 1 tbl, 9 ex
Authors
Dates
2023-06-22—Published
2018-12-13—Filed